ArticleOPEN ACCESS

Fenofibrate as a COVID-19 modifying drug: Laboratory success versus real-world reality

Atherosclerosis
DOI: 10.1016/j.atherosclerosis.2021.11.012
12Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Your institution provides access to this article.

Author supplied keywords

Cite

CITATION STYLE

APA

Feher, M., Joy, M., Munro, N., Hinton, W., Williams, J., & de Lusignan, S. (2021, December 1). Fenofibrate as a COVID-19 modifying drug: Laboratory success versus real-world reality. Atherosclerosis. Elsevier Ireland Ltd. https://doi.org/10.1016/j.atherosclerosis.2021.11.012

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free